BIOXYTRAN, INC Business Finance Contracts & Agreements
64 Contracts & Agreements
- Debenture Agreements (4 contracts)
- Exchange Agreements (1)
- Note Agreements (16)
- Purchase Agreements (18)
- Registration Rights Agreements (2)
- Security Agreements (2)
- Stock Agreements (6)
- Subscription Agreements (4)
- Warrant Agreements (11)
- Certificate of Designation of Convertible Preferred Stock, dated April 19, 2024 (Filed With SEC on April 19, 2024)
- Option Agreement for conversion/exchange between Pharmalectin, Inc. and Bioxytran, Inc. shares of Common Stock, dated November 20, 2021 (Filed With SEC on April 19, 2024)
- Securities Purchase Agreement between Bioxytran, Inc. and Lender, dated March 15, 2024 (Filed With SEC on March 22, 2024)
- 8% Convertible Note of Bioxytran, Inc. to Lender in the Principal Amount of $61,500 dated March 15, 2024 (Filed With SEC on March 22, 2024)
- Debt Modification Agreement with Note Holder, dated May 5, 2023 (Filed With SEC on September 19, 2023)
- Form of Subscription Agreement (Filed With SEC on May 12, 2023)
- Form of Private Purchase Agreement (Filed With SEC on May 12, 2023)
- Form of Subscription Agreement (Filed With SEC on August 17, 2022)
- Form of Note Purchase Agreement, dated January 5, 2022 (Filed With SEC on January 14, 2022)
- Form of Convertible Note, dated January 5, 2022 (Filed With SEC on January 14, 2022)
- Form of Warrant dated June 4, 2021 (Filed With SEC on November 17, 2021)
- 2017 Employee, Director and Consultant Stock Plan (Subsidiary), adopted by the Board of Directors on October 5, 2017 (Filed With SEC on June 24, 2021)
- 2021 Employee, Director and Consultant Stock Plan, adopted by the Board of Directors on January 19, 2021 (Filed With SEC on June 24, 2021)
- Form of Convertible Note Agreement between Note Holders and Bioxytran, Inc., dated May 2 and 3, 2021 (Filed With SEC on June 7, 2021)
- 8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $64,900 dated March 18, 2020 (Filed With SEC on March 26, 2020)
- Securities Purchase Agreement between Power Up Lending Group LLC and Bioxytran, Inc., dated March 18, 2020 (Filed With SEC on March 26, 2020)
- Amendment #1 to Securities Purchase Agreement between Auctus Fund LLC and Bioxytran, Inc., dated February 25, 2019 (Filed With SEC on March 12, 2020)
- Amendment #1 to Securities Purchase Agreement between Auctus Fund LLC and Bioxytran, Inc., dated October 24, 2018 (Filed With SEC on March 12, 2020)
- Warrant to Purchase 22,000 shares of Common Stock of Bioxytran (Filed With SEC on February 26, 2020)
- 4% Convertible Note of Bioxytran, Inc. to Crown Bridge Partners, LLC in the Principal Amount of $55,000 dated October 30, 2019 (Filed With SEC on February 26, 2020)
- Securities Purchase Agreement between Crown Bridge Partners, LLC and Bioxytran, Inc., dated October 30, 2019 (Filed With SEC on February 26, 2020)
- 8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $56,600 dated January 18, 2020 (Filed With SEC on February 26, 2020)
- Securities Purchase Agreement between Power Up Lending Group LLC and Bioxytran, Inc., dated January 18, 2020 (Filed With SEC on February 26, 2020)
- Warrant to Purchase 50,000 shares of Common Stock of Bioxytran (Filed With SEC on January 15, 2020)
- 4% Convertible Note of Bioxytran, Inc. to EMA Financial LLC. in the Principal Amount of $125,000 dated January 10, 2020 (Filed With SEC on January 15, 2020)
- Securities Purchase Agreement between EMA Financial LLC and Bioxytran, Inc., dated January 10, 2020 (Filed With SEC on January 15, 2020)
- 8% Convertible Note of Bioxytran, Inc. to Power Up Lending Group in the Principal Amount of $54,600 dated December 30, 2019 (Filed With SEC on January 6, 2020)
- Securities Purchase Agreement between Power Up Lending Group and Bioxytran, Inc., dated December 30, 2019 (Filed With SEC on January 6, 2020)
- Warrant to Purchase 50,000 shares of Common Stock of Bioxytran (Filed With SEC on November 25, 2019)
- 4% Convertible Note of Bioxytran, Inc. to FirstFire Global Opportunities Fund, LLC. in the Principal Amount of $125,000 dated November 20, 2019 (Filed With SEC on November 25, 2019)
- Securities Purchase Agreement between FirstFire Global Opportunities Fund, LLC and Bioxytran, Inc., dated November 20, 2019 (Filed With SEC on November 25, 2019)
- Form of Warrant to Purchase 50,000 shares of Common Stock of Bioxytran (Filed With SEC on November 12, 2019)
- Form of 4% Convertible Note of Bioxytran, Inc. to GS Capital Partners, LLC. in the Principal Amount of $125,000 dated November 7, 2019 (Filed With SEC on November 12, 2019)
- Form of Securities Purchase Agreement between GS Capital Partners, LLC and Bioxytran, Inc., dated No ember 7, 2019 (Filed With SEC on November 12, 2019)
- 8% Convertible Note of Bioxytran, Inc. to PowerUp Lending Group Ltd. in the Principal Amount of $106,000 dated October 21, 2019 (Filed With SEC on November 5, 2019)
- Securities Purchase Agreement between PowerUp Lending Group Ltd. and Bioxytran, Inc., dated October 21, 2019 (Filed With SEC on November 5, 2019)
- Warrant to Purchase 50,000 shares of Common Stock of Bioxytran (Filed With SEC on November 5, 2019)
- 8% Convertible Note of Bioxytran, Inc. to Tangiers Global, LLC in the Principal Amount of $106,300 dated October 23, 2019 (Filed With SEC on November 5, 2019)
- Warrant to Purchase 50,000 shares of Common Stock of Bioxytran (Filed With SEC on November 5, 2019)
- Convertible Debenture of Bioxytran, Inc. to Peak One Opportunity Fund, L.P. in the Principal Amount of $120,000 dated October 22, 2019 (Filed With SEC on November 5, 2019)
